Skip to main content

Publications


 Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy. Nagaraja SreeHarsha, R Maheshwari, Bandar E Al-Dhubiab, M Tekade, M Sharma, N Venugopala, Rakesh Tekade, Abdullah M Alzahrani. International Journal of Nanomedicine, Dove Medical Press, UK. 14 7419-7429. 2019. (IF 4.47)

 Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide’. H Chuadhary, R Maheshwari, M Pandey, B Gorain, R Tekade. Material Science and Engineering-C; 106, 2020, 110275 (IF 4.9).

 Fundamentals of diffusion and dissolution: dissolution testing of pharmaceuticals D Kapoor, R Maheshwari, K Verma, S Sharma, A Pethe, RK Tekade; Drug Delivery Systems, 1-45, 2020.

 Coating technologies in pharmaceutical product development. Devesh Kapoor, Rahul Maheshwari, Kanika Verma, Swapnil Sharma, Piyush Ghode, Rakesh K.Tekade. Drug Delivery Systems, Advances in Pharmaceutical Product Development and Research, 665-719, 2020.

 “Gabapentin taste masking using β-cyclodextrin: An in vitro evaluation. Kapil Kumar. Book, Lambert Academic Publishing (ISBN: 978-620-0-44041-9), 2019.

 Specialized tablets: ancient history to modern developments. Ashika Advankar, Rahul Maheshwari, Vishakha Tambe, Pooja Todke, Nidhi Raval, Devesh Kapoor, Rakesh K.Tekade. Drug Delivery Systems; Advances in Pharmaceutical Product Development and Research, 615-664, 2020.

 Structural and clinical impact of anti-allergy agents: An overview”.Yagyesh Kapoor, Kapil Kumar. Bioorganic Chemistry. 94; 2020; 1033-1051. (IF 3.9).

 Regulatory assessment for controlled drug delivery products. Aashu Gupta, Rahul Maheshwari, Kaushik Kuche, Gillian A. Hutcheon, Rakesh K.Tekade. Drug Delivery Systems; Advances in Pharmaceutical Product Development and Research, 721-741, 2019.


Connect With Us x